| Code: MTA10117 | Publication Date: Oct 2025 |
Increasing chronic disease prevalence, healthcare initiatives by the government, and advancements in diagnostic technologies are driving the India IVD industry. Therefore, there is growing demand for in vitro diagnostic tests that improve early disease diagnosis and patient management in India.
Significant trends are impacting the India IVD market, including the growing use of molecular diagnostics and the development of point-of-care testing solutions. These innovations increase accuracy and accessibility to tests, especially in rural areas of India. Other evidence supporting the growing focus on personalised medicine with diagnostic tests specific to individual patient profiles. The use of artificial intelligence and automation in diagnostic processes is making these operations more efficient and reducing turnaround times. These trends are shaping the future of in vitro diagnostics in India.
The India IVD market is experiencing developments such as the introduction of advanced diagnostic platforms incorporating artificial intelligence and machine learning algorithms. These platforms enable more precise and rapid analysis of test results, facilitating timely medical interventions. Moreover, there is a shift towards decentralized testing models, with portable diagnostic devices allowing for testing outside traditional laboratory settings. This approach improves patient convenience and expands access to diagnostic services, particularly in underserved regions.
Some of the leading companies include: